TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24607301

Group type: EXPERIMENTAL
Intervention: RESMENA diet (30% energy from protein)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control diet (15% energy from protein)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Low-protein group (RESMENA diet)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Total protein intake
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Animal protein
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Meat protein
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Vegetable- and fish-derived proteins
Number of subjects: 96
Study: 22952756

Group type: EXPERIMENTAL
Intervention: ART cessation in primary HIV infection (PHI)
Number of subjects: 1632

Group type: COMPARATOR
Intervention: ART cessation in chronic HIV infection (CHI)
Number of subjects: 1632

Group type: COMPARATOR
Intervention: ART cessation in chronic HIV infection (CHI) with CD4 nadir >500 cells/mm(3)
Number of subjects: 1632
Study: 19085099

Group type: EXPERIMENTAL
Intervention: Diaphragm, lubricant gel, and condoms
Number of subjects: 5039

Group type: COMPARATOR
Intervention: Condoms alone
Number of subjects: 5039

Group type: EXPERIMENTAL
Intervention: Diaphragm only
Number of subjects: 5039

Group type: EXPERIMENTAL
Intervention: Diaphragm instead of condom
Number of subjects: 5039
Study: 17461317

Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch (HES)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 4% human albumin (HA)
Number of subjects: 45

Group type: COMPARATOR
Intervention: 4% succinylated gelatin (GEL)
Number of subjects: 45
Study: 15201093

Group type: EXPERIMENTAL
Intervention: Radiotherapy with concurrent chemotherapy (Group A): leucovorin (CF, 100 mg/m(2), days 1‐5), 5‐fluorouracil (5‐Fu, 500 mg/m(2), days 1‐5), cisplatin (DDP, 60 mg/m(2), day 1) for one course followed by another 4 weeks later.
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Radiotherapy with concurrent chemotherapy (Group A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Radiotherapy alone (Group B)
Number of subjects: 80
Study: 11693978

Group type: EXPERIMENTAL
Intervention: Organized or opportunistic cytology screening programmes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Targeted screening on high-risk women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reorganizing screening programmes in middle-income countries
Number of subjects: 0
Study: 9688993

Group type: EXPERIMENTAL
Intervention: Increased physical activity
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control
Number of subjects: 38
Study: 7862941

Group type: EXPERIMENTAL
Intervention: Triazolam 0.25 mg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Triazolam 0.50 mg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Zolpidem 20 mg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 2514430

Group type: EXPERIMENTAL
Intervention: Taprostene (25 ng/kg/min intravenously for 6 hours daily on 5 consecutive days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 126075

Group type: EXPERIMENTAL
Intervention: 0.1% hydrocortisone cream with vasoconstrictor activity
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1.0% Hydrocortisone Cream BPC
Number of subjects: 0
Study: 30786339

Group type: EXPERIMENTAL
Intervention: 24 h enteral nutrition group (group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 48 h enteral nutrition group (group B)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 50
Study: 29130496

Group type: EXPERIMENTAL
Intervention: Reflexology
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Meditative practices
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Additional reflexology
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Additional meditative practices
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study: 25472509

Group type: EXPERIMENTAL
Intervention: Implementation approaches of the Chronic Care Model
Number of subjects: 822

Group type: EXPERIMENTAL
Intervention: High vs. low practice Change Culture
Number of subjects: 822

Group type: EXPERIMENTAL
Intervention: High vs. low practice Work Culture
Number of subjects: 822

Group type: EXPERIMENTAL
Intervention: High vs. low variability in practice Change Culture
Number of subjects: 822

Group type: EXPERIMENTAL
Intervention: High vs. low variability in practice Work Culture
Number of subjects: 822
Study: 23750422

Group type: EXPERIMENTAL
Intervention: Special effect San Xiao decoction (1 dose/d for 12 weeks)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Metformin (0.5 g/time, oral, 2 times/d)
Number of subjects: 116
Study: 21330278

Group type: EXPERIMENTAL
Intervention: IVR + CB (4 IVR calls during the first month postdischarge)
Number of subjects: 738

Group type: COMPARATOR
Intervention: IVR (1 IVR call at 2 weeks postdischarge)
Number of subjects: 738

Group type: EXPERIMENTAL
Intervention: IVR + CB
Number of subjects: 738
Study: 19261138

Group type: EXPERIMENTAL
Intervention: Clinician aware of BNP levels (BNP group)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Blinded to BNP levels (control group)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Both groups (BNP and control)
Number of subjects: 92
Study: 16872965

Group type: EXPERIMENTAL
Intervention: No-touch technique (veins removed with surrounding tissue, not distended, stored in heparinized blood)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Conventional technique (veins stripped, distended, stored in saline solution)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: No-touch technique
Number of subjects: 104

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 104
Study: 12611783

Group type: EXPERIMENTAL
Intervention: BCAA (60 g)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 10848659

Group type: EXPERIMENTAL
Intervention: OMC (omeprazole 20 mg b.d., metronidazole 400 mg b.d., clarithromycin 250 mg b.d.)
Number of subjects: 220

Group type: COMPARATOR
Intervention: OAM (omeprazole 40 mg mane, amoxycillin 500 mg t.d.s., metronidazole 400 mg t.d.s.)
Number of subjects: 220
Study: 9122729

Group type: EXPERIMENTAL
Intervention: High-dose recombinant interferon alfa-2b (rIFN‐alpha 2b)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 0
Study: 8484286

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 600

Group type: COMPARATOR
Intervention: Open cholecystectomy
Number of subjects: 600
Study: 3094430

Group type: EXPERIMENTAL
Intervention: Varied harmonic environment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quiet ambient environment
Number of subjects: 0
Study: 30833435

Group type: EXPERIMENTAL
Intervention: Positive sentinel lymph node (SLN) with micrometastases
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Positive sentinel lymph node (SLN) with macrometastases
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Negative lymph nodes (sentinel or non-sentinel)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Isolated tumor cells on lymph nodes
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Patients aged >50 years
Number of subjects: 139
Study: 29316883

Group type: EXPERIMENTAL
Intervention: Palliative care intervention delivered over 5 months with a minimum of 7 clinical contacts.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Palliative care intervention components: weak opioid, laxatives, discussion about spiritual worries, emotional support, time to talk about worries, discussion about future and planning ahead.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Qualitative findings from the intervention group.
Number of subjects: 0
Study: 26241790

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 331

Group type: COMPARATOR
Intervention: Multiple daily injections (MDI)
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: CSII
Number of subjects: 331

Group type: COMPARATOR
Intervention: MDI
Number of subjects: 331
Study: 24450776

Group type: EXPERIMENTAL
Intervention: Sensor-augmented pump therapy
Number of subjects: 196
Study: 23171804

Group type: EXPERIMENTAL
Intervention: 5‐in‐6 double catheter technique (DC group)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Conventional buddy‐wire or balloon‐anchoring approach (control group)
Number of subjects: 187
Study: 21141772

Group type: EXPERIMENTAL
Intervention: Audio modeling only
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Audio and visual modeling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Musically trained participants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonmusically trained participants
Number of subjects: 0
Study: 17646228

Group type: EXPERIMENTAL
Intervention: IV prednisolone, 60 mg for 5 days
Number of subjects: 210

Group type: COMPARATOR
Intervention: Oral prednisolone, 60 mg for 5 days
Number of subjects: 210
Study: 14694036

Group type: EXPERIMENTAL
Intervention: neurofilament light protein (NFL)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: glial fibrillary acidic protein (GFAP)
Number of subjects: 66

Group type: COMPARATOR
Intervention: S100B
Number of subjects: 66

Group type: COMPARATOR
Intervention: neuron‐specific enolase protein (NSE)
Number of subjects: 66
Study: 10691224

Group type: EXPERIMENTAL
Intervention: 3‐ml lidocaine‐epinephrine test dose + 12 ml bupivacaine, 0.0625%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 3‐ml lidocaine‐epinephrine test dose + 12 ml bupivacaine, 0.125%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 15 ml bupivacaine, 0.0625% (no test dose)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 15 ml bupivacaine, 0.125% (no test dose)
Number of subjects: 60

Group type: COMPARATOR
Intervention: All groups (including both test dose and no test dose)
Number of subjects: 60
Study: 9233096

Group type: EXPERIMENTAL
Intervention: Transarterial (TA) technique
Number of subjects: 57

Group type: COMPARATOR
Intervention: Peripheral nerve stimulator (PNS) technique
Number of subjects: 57

Group type: COMPARATOR
Intervention: Both techniques (TA and PNS)
Number of subjects: 57
Study: 8140383

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (200 micrograms) aqueous nasal spray (FPANS) twice daily
Number of subjects: 251

Group type: COMPARATOR
Intervention: Beclomethasone dipropionate (200 micrograms) aqueous nasal spray (BDPANS) twice daily
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (200 micrograms) aqueous nasal spray (FPANS) and Beclomethasone dipropionate (200 micrograms) aqueous nasal spray (BDPANS)
Number of subjects: 251
Study: 3945437

Group type: EXPERIMENTAL
Intervention: melphalan, 5-fluorouracil, and medroxyprogesterone acetate with or without tamoxifen
Number of subjects: 50
Study: 30039776

Group type: EXPERIMENTAL
Intervention: Digoxin used by 11/14 centres in 25% of patients (23-31%)
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Bidirectional Glenn procedure
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Deep hypothermic circulatory arrest
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: ICU length of stay
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Total length of stay
Number of subjects: 397
Study: 27232052

Group type: EXPERIMENTAL
Intervention: Vilazodone 20-40 mg/d
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 24853923

Group type: EXPERIMENTAL
Intervention: Thoracic spine manipulation (TSM)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 97
Study: 22410375

Group type: EXPERIMENTAL
Intervention: Diacetylmorphine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 0
Study: 20189517

Group type: EXPERIMENTAL
Intervention: Argon plasma coagulation (APC) in addition to biofeedback therapy (BT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard care only (biofeedback therapy [BT])
Number of subjects: 24
Study: 18180641

Group type: EXPERIMENTAL
Intervention: Behavioral Indicators of Infant Pain (BIIP) scale during blood collection (procedure A)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Behavioral Indicators of Infant Pain (BIIP) scale during blood collection preceded by a diaper change (procedure B)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Heart Rate (HR) during blood collection (procedure A)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Heart Rate (HR) during blood collection preceded by a diaper change (procedure B)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Heart Rate (HR) during Lance phase between procedure A and B
Number of subjects: 69
Study: 16194181

Group type: EXPERIMENTAL
Intervention: Posturing face down following macular hole surgery
Number of subjects: 18

Group type: COMPARATOR
Intervention: Two different posturing regimes
Number of subjects: 18
Study: 12853795

Group type: EXPERIMENTAL
Intervention: Serum protein profiling by surface enhanced laser desorption/ionization time of flight mass spectrometry
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Combined spectral data from the weak cation exchange and copper metal affinity capture arrays
Number of subjects: 106
Study: 10371089

Group type: EXPERIMENTAL
Intervention: Active SIT with allergoid extract of Parietaria pollen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo group (switched to active SIT after year 1)
Number of subjects: 0
Study: 8814688

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with cisplatin and etoposide (EP) combined with cranial and local radiotherapy
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy with vincristine, doxorubicin and cyclophosphamide (VAC)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy with VAC
Number of subjects: 202

Group type: COMPARATOR
Intervention: Overall survival (OS) and disease-free survival (DFS)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Induction regimen (EP combined with radiotherapy)
Number of subjects: 202
Study: 2005223

Group type: EXPERIMENTAL
Intervention: Intensive oral hygiene instructions, scaling and root planing (OH group)
Number of subjects: 27

Group type: COMPARATOR
Intervention: No treatment (no treatment group)
Number of subjects: 27
Study: 6152739

Group type: EXPERIMENTAL
Intervention: ICI 118.551 (50 or 100 mg t.i.d.)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 31420360

Group type: EXPERIMENTAL
Intervention: Intensive therapy (experimental arm with altered fractionation and/or multiagent concurrent systemic therapy)
Number of subjects: 2688
Study: 29544423

Group type: EXPERIMENTAL
Intervention: Cardiac Rehabilitation (CR)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 28
Study: 26700487

Group type: EXPERIMENTAL
Intervention: Web-based motivational enhancement intervention
Number of subjects: 422

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 422
Study: 24383505

Group type: EXPERIMENTAL
Intervention: β-alanine supplementation
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 21742531

Group type: EXPERIMENTAL
Intervention: Multiple drilling combined with alendronate
Number of subjects: 93

Group type: COMPARATOR
Intervention: Multiple drilling alone
Number of subjects: 93
Study: 19708633

Group type: EXPERIMENTAL
Intervention: Locked plating
Number of subjects: 58

Group type: COMPARATOR
Intervention: External fixation
Number of subjects: 58
Study: 17697218

Group type: EXPERIMENTAL
Intervention: ProSeal LMA
Number of subjects: 100

Group type: COMPARATOR
Intervention: Tracheal tube
Number of subjects: 100
Study: 12925469

Group type: EXPERIMENTAL
Intervention: Sevoflurane/remifentanil (<=0.1 microg kg(‐1) min(‐1))
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sevoflurane/remifentanil (>=0.2 microg kg(‐1) min(‐1))
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Propofol/remifentanil (<=0.1 microg kg(‐1) min(‐1))
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Propofol/remifentanil (>=0.2 microg kg(‐1) min(‐1))
Number of subjects: 40

Group type: COMPARATOR
Intervention: BIS
Number of subjects: 40

Group type: COMPARATOR
Intervention: PSI
Number of subjects: 40
Study: 11058007

Group type: EXPERIMENTAL
Intervention: Normal participants performing with maximum effort
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participants faking hand weakness
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients recovering from carpal tunnel surgery
Number of subjects: 0
Study: 8877887

Group type: EXPERIMENTAL
Intervention: Multidose nebulizer (200 x 15 microL doses of flunisolide, 250 micrograms)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Pressurized metered dose inhaler (MDI, 250 micrograms of flunisolide)
Number of subjects: 10

Group type: COMPARATOR
Intervention: MDI plus Inhacort spacer (250 micrograms of flunisolide)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Multidose nebulizer
Number of subjects: 10

Group type: COMPARATOR
Intervention: MDI
Number of subjects: 10

Group type: COMPARATOR
Intervention: MDI plus Inhacort spacer
Number of subjects: 10
Study: 1642345

Group type: EXPERIMENTAL
Intervention: Morphine (1 mg in 20 ml NaCl)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Bupivacaine (20 ml, 0.25%)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Combination of morphine and bupivacaine
Number of subjects: 33
Study: 6134536

Group type: EXPERIMENTAL
Intervention: Pancuronium 0.08 mg kg‐1
Number of subjects: 20

Group type: COMPARATOR
Intervention: Vecuronium 0.057 mg kg‐1
Number of subjects: 20
Study: 31200685

Group type: EXPERIMENTAL
Intervention: La Vida Buena (LVB) 8-week family-focused intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single educational session
Number of subjects: 0
Study: 27444007

Group type: EXPERIMENTAL
Intervention: Intravitreal ocriplasmin (0.1 ml)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Transconjunctival vitrectomy
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Intravitreal ocriplasmin
Number of subjects: 39
Study: 26280786

Group type: EXPERIMENTAL
Intervention: Ledipasvir/Sofosbuvir (LDV/SOF) + Ribavirin (RBV)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ledipasvir/Sofosbuvir (LDV/SOF)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ledipasvir/Sofosbuvir (LDV/SOF) without Ribavirin (RBV)
Number of subjects: 100
Study: 23486618

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided (US) facet joint injections
Number of subjects: 40

Group type: COMPARATOR
Intervention: Computed Tomography (CT)-controlled interventions
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (US and CT)
Number of subjects: 40
Study: 21859789

Group type: EXPERIMENTAL
Intervention: ROCsafeRX (minimized perfusion circuits)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Standard cardiopulmonary bypass
Number of subjects: 500
Study: 19220605

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control
Number of subjects: 97
Study: 16698524

Group type: EXPERIMENTAL
Intervention: Diclofenac patch
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard skin medication (placebo; control group)
Number of subjects: 120
Study: 15637637

Group type: EXPERIMENTAL
Intervention: Venlafaxine IR (n = 17)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (n = 15)
Number of subjects: 32
Study: 10234578

Group type: EXPERIMENTAL
Intervention: Gross motor activity program (15-20 minutes/day, 5 days/week)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Fine motor activity program
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Gross motor activity program (compliant infants)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Calcium intake (moderately high)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Calcium intake (low)
Number of subjects: 72
Study: 9495784

Group type: EXPERIMENTAL
Intervention: Immunological and antiviral treatment (SRE, Moroxidin, Antiherpin)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Symptomatic therapy only (Control group)
Number of subjects: 2
Study: 1807871

Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 25
Study: 6887843

Group type: EXPERIMENTAL
Intervention: Transfer Test (TT)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Fibrin(ogen) degradation products (FDP)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Ethanol Gelatin Test (EGT)
Number of subjects: 211
Study: 30336373

Group type: EXPERIMENTAL
Intervention: Moderate to severe anxiety
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Moderate to severe depression
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Severe cognitive impairments
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Chewing tobacco
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Negative perception about elderly-friendly society
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Physical inactivity
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 244
Study: 28823950

Group type: EXPERIMENTAL
Intervention: Positive training (n = 40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Negative training (n = 40)
Number of subjects: 80
Study: 27129892

Group type: EXPERIMENTAL
Intervention: Physical activity with diet-induced weight loss
Number of subjects: 11

Group type: COMPARATOR
Intervention: Post-intervention subjects
Number of subjects: 11

Group type: COMPARATOR
Intervention: Succinate dehydrogenase and fiber type
Number of subjects: 11
Study: 25330671

Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Combined Spinal‐Epidural Anesthesia (CSEA)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Epidural Anesthesia (EA)
Number of subjects: 133
Study: 22632824

Group type: EXPERIMENTAL
Intervention: Experimental group (packaging materials stored for various intervals)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study: 20143328

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing‐Single (MI‐Single)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing‐Group (MI‐Group)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Nurse‐Led Hepatitis Health Promotion (HHP)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 256